Treatment of hyperprolactinemic conditions with bromoergocryptine
Sas, M.; Godó, G.; Morvay, J.
Zentralblatt für Gynakologie 100(22): 1501-1507
1978
ISSN/ISBN: 0044-4197 PMID: 570784 Document Number: 129532
Ten hyperprolactinemic patients were treated by a daily dose of 5 mg bromergocryptine (Parlodel, Sandoz). The prolactine concentration in the peripherial blood showed a fast declind and after two months the patients were relieved from the symptoms (galactorrhea, amenorrhea). As side-effects of the compound headache and nausea were noted.
Document emailed within 1 workday
Related Documents
Nagy, P.; Szilágyi, A.; Csaba, I. 1986: Experience with the treatment of hyperprolactinemic conditions Orvosi Hetilap 127(10): 573-576Ovsiannnikova, T.V.; Pshchenichnikova, T.I.; Kovneeva, I.E. 1988: Various treatment regimens in infertility using bromoergocryptine in women with hyperprolactinemia Acta Universitatis Palackianae Olomucensis Facultatis Medicae 119: 557-561
Sumi, C.; Yokoro, K.; Matsushima, R. 1983: Suppression of diethylstilbestrol and N-nitrosobutylurea-induced mammary and pituitary tumorigenesis in rats by prolonged treatment with 2-bromoergocryptine Cancer Research 43(10): 4781-4785
Barreca, P.; Giannola, C.; Palisi, F. 1978: 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment Acta Europaea Fertilitatis 9(1): 21-29
Justus, B.; Richter, B.; Seiler, E.; Held, H.J.; Köhler, K.; Schaps, P. 1985: Results of treatment in the hyperprolactinemic anovulatory syndrome Zentralblatt für Gynakologie 107(21): 1296-1299
Katz, Z.; Borenstein, R.; Lancet, M. 1981: Combined bromocryptine and hMG treatment in hyperprolactinemic infertility International Journal of Fertility 26(4): 290-292
Veĭnberg, E.G.; Vepkhvadze, R.I.; Kapanadze, B.B.; Sabakhtarashvili, M.A.; Gorgoshidze, B.V. 1984: Diagnostic value of roentgenography in the hyperprolactinemic syndrome Vestnik Rentgenologii i Radiologii 6: 48-52
Friesen, H.G. 1980: Bromocriptine therapy of hyperprolactinemic disorders Advances in Biochemical Psychopharmacology 23: 147-154
Abraham, G. 1982: Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states Progress in Clinical and Biological Research 112 Pt A: 255-273
Romero, C.; León, J.; Jara, R.; González, O. 1993: Importance of prolactin isoforms on ovary function in hyperprolactinemic women Revista Chilena de Obstetricia y Ginecologia 58(6): 465-469
Kulakov, V.I.; Prilepskaia, V.N.; Baklaenko, N.G.; Laricheva, I.P. 1981: Experience with using pergonal in endocrine sterility with hyperprolactinemic amenorrhea patients Akusherstvo i Ginekologiia 2: 26-28
Isakov, A.V.; Potin, V.V.; Svechnikova, F.A.; Iumatova, T.D. 1986: Gonadotropic activity of the hypophysis and ovarian endocrine function in hyperprolactinemic amenorrhea Problemy Endokrinologii 32(1): 32-35
Potin, V.V.; Miasnikova, G.P.; Prorokova, V.K.; Svechnikova, F.A. 1986: Hyperprolactinemic ovarian insufficiency in women experiencing massive blood loss during labor Akusherstvo i Ginekologiia 10: 26-29
Langner, T.K.; Mel'nichenko, G.A.; Dedov, I.I.; Saakian, O.A.; Gitel', E.P. 1986: Diagnostic value of pharmacological tests and roentgenoradiological methods in the diagnosis of various forms of hyperprolactinemic hypogonadism Akusherstvo i Ginekologiia 7: 29-32
Fossati, P.; Strauch, G.; Tourniaire, J. 1976: Study of the action of bromocriptine in hyperprolactinemic states. Results of a cooperative trial in 135 patients La Nouvelle Presse Medicale 5(27): 1687-1691
Giusti, M.; Foppiani, L.; Fazzuoli, L.; Molinari, E.; Guido, R.; Valenti, S.; Giordano, G. 1999: An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs Recenti Progressi in Medicina 90(3): 147-151
Lewinthal, D.; Corenblum, B.; Taylor, P.J. 1987: Prolactin response to clomiphene citrate is different in hyperprolactinemic polycystic ovary syndrome and idiopathic hyperprolactinemia International Journal of Fertility 32(3): 185-187; 191
Nappi, C.; Mercorio, F.; Nappi, F.; Del Giudice, M.; Trezza, G. 1981: Ovarian refractoriness to gonadotropins and evaluation of estrogen-prolactin feedback in hyperprolactinemic states: experimental studies Archivio di Ostetricia E Ginecologia 86(3-4): 145-153
Cepický, P.; Burdová, I.; Sulková, S.; Roth, Z.; Stroufová, A. 1986: Psychological and physiological factors in the etiology of hyperprolactinemic disorders of the menstrual cycle in women in a regular hemodialysis program Ceskoslovenska Gynekologie 51(4): 251-257
Nicoletti, I.; Filipponi, P.; Fedeli, L.; Angeletti, G.; Santeusanio, F.; Brunetti, P. 1981: Effect of methyl-p-tyrosine administration on gonadotropin and prolactin release in normal-cycling, postmenopausal and hyperprolactinemic women Acta Europaea Fertilitatis 12(3): 271-273